English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  50905330    ???header.onlineuser??? :  595
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"john wen cheng chang"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-7 of 7  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
義守大學 2017-06 Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities Chia-Yu Chu;Kuan-Yu Chen;John Wen-Cheng Chang;Yu-Feng Wei;Chih-Hung Lee;Wei-Ming Wang
國立臺灣海洋大學 2015 Cytoplasmic and nuclear parathyroid hormone-related proteins are opposing prognostic factors in patients with non-small-cell lung cancer who have undergone curative resection Chiao-En Wu; Chi-Wei Wang; Wen-Kuan Huang; Cheng-Ta Yang; Yi-Cheng Wu; Ming-Mo Hou; Chia-Hsun Hsieh; Jia-Juan Hsieh; Hsin-Yi Cheng; Todd Hsu; John Wen-Cheng Chang
國立臺灣海洋大學 2012 Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms JOHN WEN-CHENG CHANG;NIEN-CHIH WEI;HUNG-JU SU;JIE-LEN HUANG;TSE-CHING CHEN;YI-CHENG WU;CHIH-TENG YU;MING-MO HOU;CHIA-HSUN HSIEH;JIA-JUAN HSIEH;CHIAO-EN WU;HSIN-YI CHENG;TODD HSU;TZU-HAO WANG
國立臺灣海洋大學 2012 Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterations MING-MO HOU;SHIU-FENG HUANG;HAN-PIN KUO;CHENG-TA YANG;YING-HUANG TSAI;CHIH-TENG YU;HORNG-CHYUAN LIN;CHIH-HUNG CHEN;CHIH-LIANG WANG;FU-TSAI CHUNG;JIA-JUAN HSIEH;TODD HSU;HSIN-YI CHENG;LI-YING OU;HUNG-MING WANG;YUNG-CHANG LIN;NAI-JEN CHANG;JOHN WEN-CHENG CHANG
中國醫藥大學 2011-06 Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan. (Myung-Ju AHN)*;(Chun-Ming TS);夏德椿(Te-Chun Hsia);(Elaine WRIGHT);(John Wen-Cheng CHANG);(Heung Tae KIM)
國立臺灣海洋大學 2009-06 Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells John Wen-Cheng Chang;Jia-Juan Hsieh;Yung-Chi Shen;Kun-Yun Yeh;Cheng-Hsu Wang;Ying-Ying Li;Todd Hsu
國立臺灣海洋大學 2007-12 Erlotinib response of EGFR-mutant gefitinib-resistant non-small-cell lung cancer John Wen-Cheng Chang;Chun-Liang Chou;Shiu-Feng Huang;Hung-Ming Wang;Jia-Juan Hsieh;Todd Hsu;Yun-Chung Cheung

Showing items 1-7 of 7  (1 Page(s) Totally)
1 
View [10|25|50] records per page